High-quality reagents at extremely competitive prices. With over 100 years of relevant experience in our leadership team, we believe that we are uniquely positioned to facilitate our vision of Making Science Affordable.

About Us

Founded in 2017, 3CR Bioscience Limited is led by a group of scientists who have built close ties together working for 20 years in R&D, product development and manufacturing, and who wanted to make high-quality scientific reagents affordable for all. We share the belief that more affordable reagents will empower scientists to produce more data, with better outcomes, accelerating all areas of science for positive change.

About us


Discover for yourself why 3CR Bioscience is a trusted partner for marker assisted breeding programs wordwide, from large seed and livestock producers to individual breeders feeding local communities.

100 years of marker assisted breeding

Over 100 years experience in R&D, new product development, manufacturing and quality control.

Marker assisted breeding quality control

Extensive quality-control processes.

Quick marker assisted breeding

Quick turnaround times on orders.

Customisation icon

Free PACE assay design service for users

Marker assisted breeding after sales support

Knowledgeable after sales support.

Meet our Senior Leadership team

A company forged through decades of high-throughput genotyping innovation, founded and operated by scientists dedicated to serving the scientific commuity.

Quality Control

Quality is more than making a good product, at 3CR Bioscience it is our fundamental principle. After all, customers are paying for products that they expect to work well and consistently. We are continuously looking to improve our products and processes.

Our team have decades of experience in reagent quality control (QC) and we have used this extensive knowledge to develop a QC protocol that ensures our mixes perform to the highest standards, reproducibly with each and every batch.

To ensure that our products are suitable for delivery to customers, we apply a rigorous QC procedure to every batch, not only testing the mix to set parameters, but also running comparison tests against historical batches of mix that had previously passed QC.

Quality control in the lab


At 3CR Bioscience, we understand the frustration in ordering a product and expecting it to be delivered in a timely manner, only to find that it will take several weeks before the product is delivered.

That is why we make a commitment to our customers to mitigate against this concern.

We ship products to different territories only on selected days, to minimise any potential delays caused by weekends. You will find our shipping days below.


Shipping on Monday, Tuesday or Friday with delivery expected to take 2-3 days.


Shipping on Monday, Tuesday or Friday with delivery expected to take 2-4 days.


Shipping on Monday or Friday with delivery expected to take approximately 1 week.


Shipping on Monday or Friday with delivery expected to take approximately 1 week.

0 – 2 L

Ship all orders within two working days of an order being placed for orders up to 2 L (or first available shipping day after this for your territory).

2 – 12 L

For orders larger than 2 L, where possible, we will ship the whole order within two working days. If we are unable to ship the whole order, we will ship the first 2 L of the order within two working days and the remainder of the order within one week.

+ 12 L

For customers ordering more than 12 L per year, we are happy to allow the customers to hold one month of stock on their site, as an un-invoiced back-up supply of our products.


This field is for validation purposes and should be left unchanged.
This field is for validation purposes and should be left unchanged.

Contact us


Steve Asquith Managing Director
Steve began his career in the Genetics Division of GlaxoSmithKline, as part of the team establishing GSK’s high-throughput core genotyping laboratory. Steve joined KBioscience when it was first founded in 2002 and was a key driver in taking the company from a small start-up to a multi-national service laboratory, quickly growing the company’s revenue to over $7.5M p.a. Following the acquisition of Kbioscience by LGC in 2011, Steve was appointed Global Director of Operations for LGC Genomics, responsible for over 100 staff in Europe and N. America, successfully elevating the genotyping products and service business. Steve held a crucial leadership role until he left in 2016. In 2017 Steve joined forces with John Holme to create 3CR Bioscience, a new company with a mission to deliver outstanding, customer-focused genotyping products with innovation and affordability at its core.
Dr. John Holme Technical Director
John joined KBioscience shortly after it was founded, in 2003, and became Head of Technical Development, building the company’s genotyping and DNA extraction product portfolio and service delivery until 2011 when it was acquired by LGC. Post-acquisition, John was appointed Head of Technical Group for LGC Genomics, in charge of all Research & Development and Technical Support activities for the company. In this role John continued to build on the high-quality products and services provided to the companies growing customer base. During the 19 years John has worked in commercial R&D, he has co-invented numerous highly successful products including PACE®, ProbeSure, KASP™, KlearKall, KlearGene, KlearAmp and KlearTaq™, creating breakthrough offerings in genotyping and extraction and generating huge revenues for the companies he has worked in. In 2017, he joined forces with Steve Asquith and started 3CR Bioscience. John is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.
Dr. Nisha JainOperations Director
Nisha has been innovating since the start of her career at Geneform Technologies developing Iso-thermal Genotyping Technologies. Nisha joined KBioscience in 2008, as Senior R&D Scientist and key account Technical Support Scientist, developing KASP and Klearkall performance and coinventing two further versions of KASP. Nisha has more than 15 years’ experience working in molecular biology and genotyping technologies, with extensive experience in the areas of R&D, Quality Assurance and Customer Technical Support. She has technically assisted many giants of the industry with their protocol development and troubleshooting and continues to deliver high-quality support and guidance. In 2018, Nisha joined 3CR Bioscience as Operations Director where she continues to develop PACE and ProbeSure for an increasing range of applications, and to grow 3CR Bioscience’s new product pipeline. Nisha is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.
Nazma Saffin General Manager
For 20 years Nazma Saffin has worked and gained extensive expertise within the genotyping sector. Working at Kbioscience and then LGC, she has held operational leadership posts responsible for manufacturing and laboratory services. With experience of ISO 9001 implementation, production scale up and LEAN operations, Nazma has successfully led highly profitable production departments. Joining 3CR Bioscience in 2022, Nazma is committed to delivering operational excellence.
Jon Curtis Non-Executive Chair
After 8 years in The Royal Air Force, Jon moved to the Imperial Cancer Research Fund where he pioneered the use of ultra high-throughput genomic automation, capable of 46,000 PCRs per hour. In the 1990’s Jon joined GlaxoSmithKline, implementing a high-throughput genomics platform into their drug discovery pipeline. Whilst there he also developed acoustic mixing into compound management, becoming the gold standard across pharma. Jon developed the world’s first commercially viable 1536-well PCR plates, automated thermal & laser plate-sealer, plus automated liquid-handling & tip washing tools to reduce waste and costs. In 2002 Jon co-founded KBioscience with Phil Robinson, utilising ultra high-throughput PCR instrumentation & a suite of automation tools to create the company’s SNPline robotic platform, with a capacity of 250,000 PCRs/day. The business was underpinned by their ground-breaking patented genotyping chemistry, KASP™, which has over 10,000 scientific papers to date. In November 2022 Jon joined 3CR Bioscience acting as an advisor bringing his commercial and scientific experience to the company.